[Management of age-related macular degeneration]

Management of age-related macular degeneration. Age-related macular degeneration (ARMD) is the commonest overall cause of irreversible blindness in patients aged 50 or over in the western world. The disease has been traditionally classified into early and late stages with its dry and wet forms. Patients with age-related maculopathy should consider taking a dietary supplement such as that used in AREDS. There is no effective treatment for geographic atrophy. Anti-vascular endothelial growth factor (VEGF) therapy has revolutionized the treatment of exudative ARMD. We must not forget visual rehabilitation approaches, such as low-vision rehabilitation and optical aids, while waiting to be able to obtain a restoration of the visual function (opto-genetic therapy, Stem cells, artificial retina...).